UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

Dr Nicholas Silvestri looks ahead to new data on existing agents and emerging therapies for myasthenia gravis.

In this article, we are going to take a look at where Archer Aviation Inc. (NYSE:ACHR) stands against other last week’s best-performing stocks. Ten firms outperformed Wall Street’s three major ...

In the latest market close, Archer Aviation Inc. (ACHR) reached $8.28, with a -0.96% movement compared to the previous day. This change lagged the S&P 500's daily loss of 0.22%. At the same time ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data expected in 2025. Click for my IMVT update.

In this article, we are going to take a look at where Archer Aviation Inc. (NYSE:ACHR) stands against other defense stocks that are gaining this week. European markets closed higher on Tuesday ...

Shares of ACHR stock opened at $8.10 on Wednesday. Archer Aviation Inc. has a one year low of $2.82 and a one year high of $12.48. The company has a debt-to-equity ratio of 0.16, a quick ratio of ...

Archer Aviation : Southwest Airlines Signs MOU With Archer Aviation to Develop Operational Concepts for Air Taxi Network Southwest Airlines Co. (NYSE:LUV) and Archer Aviation Inc. (NYSE:ACHR) have ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR antibodies), ...